On May 16, 2022, Landos Biopharma, Inc. appointed Patrick Truesdell to serve as principal accounting officer, effective immediately. Patrick Truesdell, age 41, has served as the Company's vice president and controller since May 2022. Prior to joining the Company, Mr. Truesdell served as Vice President, Finance and Controller at Gemini Therapeutics, Inc. from October 2021 through April 2022.

On May 16, 2022, the Company appointed Tim M. Mayleben, the Company's interim president, to also serve as principal financial officer, effective immediately.